These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Caution for psychiatrists: malignant hyperthermia risks with the anesthetic agent succinylcholine (Suxamethonium) during electroconvulsive therapy. Nakano M; Funayama M; Takata T; Wakisaka R; Koyama G; Koreki A; Ishida T; Uchida H; Mimura M BMC Psychiatry; 2024 Jun; 24(1):411. PubMed ID: 38834964 [TBL] [Abstract][Full Text] [Related]
3. Malignant hyperthermia during ECT. Lazarus A; Rosenberg H Am J Psychiatry; 1991 Apr; 148(4):541-2. PubMed ID: 2006702 [No Abstract] [Full Text] [Related]
4. More on ECT and malignant hyperthermia. Johnson GC; Santos AB Am J Psychiatry; 1983 Feb; 140(2):266-7. PubMed ID: 6849456 [No Abstract] [Full Text] [Related]
5. ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome. Addonizio G; Susman VL J Clin Psychiatry; 1987 Mar; 48(3):102-5. PubMed ID: 2880837 [TBL] [Abstract][Full Text] [Related]
6. Neuroleptic malignant syndrome and mivacurium: a safe alternative to succinylcholine? Kelly D; Brull SJ Can J Anaesth; 1994 Sep; 41(9):845-9. PubMed ID: 7955001 [TBL] [Abstract][Full Text] [Related]
14. Risk of malignant hyperthermia among patients with neuroleptic malignant syndrome and their families. Hermesh H; Aizenberg D; Lapidot M; Munitz H Am J Psychiatry; 1988 Nov; 145(11):1431-4. PubMed ID: 3189603 [TBL] [Abstract][Full Text] [Related]
15. A 20-Year-Old-Trauma Patient With Suspected Malignant Hyperthermia Following Induction With Succinylcholine: A Case Study. Luckey-Smith K; High K Adv Emerg Nurs J; 2018; 40(3):171-175. PubMed ID: 30059371 [TBL] [Abstract][Full Text] [Related]
16. ECT use for a patient with malignant hyperthermia. Franks RD; Aoueille B; Mahowald MC; Masson N Am J Psychiatry; 1982 Aug; 139(8):1065-6. PubMed ID: 7091436 [TBL] [Abstract][Full Text] [Related]
17. [Mild variant of malignant hyperthermia following succinylcholine and halogenated agent exposure]. Fernández-García V; Bermejo MA; Vázquez C; Pereda MJ; Altarriba JM; Alvarez E Rev Esp Anestesiol Reanim; 1995 Nov; 42(9):401-2. PubMed ID: 8584782 [No Abstract] [Full Text] [Related]
19. Rapacuronium: an alternative to succinylcholine for electroconvulsive therapy. Kadar AG; Kramer BA; Barth MC; White PF Anesth Analg; 2001 May; 92(5):1171-2. PubMed ID: 11323342 [No Abstract] [Full Text] [Related]
20. Masseter spasm with anesthesia: incidence and implications. Schwartz L; Rockoff MA; Koka BV Anesthesiology; 1984 Dec; 61(6):772-5. PubMed ID: 6507932 [No Abstract] [Full Text] [Related] [Next] [New Search]